Steroid-induced fibroblast growth factors drive an epithelial-mesenchymal inflammatory axis in severe asthmaRiccardo Guidi, Mark S. Wilson, Wyne P. Lee et al.|Science Translational Medicine|2022Cited by 16
Combined antagonism of Oncostatin M (OSM) and Interleukin 6 (IL-6) provides both anti-fibrotic and anti-inflammatory benefit in pulmonary fibrosisRojo Ratsimandresy, Mark S. Wilson, Emma Doran et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 0